ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

More Minorities, Women, Fewer MD On Study Sections

September 2, 1988

CMS Abandons Proposal To Require Further Certification Of Clinical Trials For Coverage.

October 19, 2007

In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants

May 11, 1979

Elias Zerhouni Nominated for NIH Director; Richard Carmona For Surgeon General

April 5, 2002

RFA Available

January 15, 1999

Genetic Testing: No Easy Answers To Public Questions

May 15, 1998